We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
GLOBETECH PUBLISHING LLC

Download Mobile App




FDA Warns Against Thermography Breast Cancer Detection

By MedImaging International staff writers
Posted on 11 Mar 2019
Print article
Thermography should not be used as an alternative to mammography for breast cancer screening or diagnosis, warns the US Food and Drug Administration (FDA; Silver Spring, MD, USA).

The FDA safety communication was issued to alert women, health care providers, and those wishing to undergo breast cancer screening that thermography is not an effective alternative to mammography, and should not be used in place of mammography for breast cancer screening or diagnosis. The safety communication followed a warning letter issued on February 22, 2019, to Total Thermal Imaging (La Mesa, CA, USA) for marketing and promoting thermography devices for uses that have not received marketing clearance or approval.

The FDA clarified that thermography devices, also known as digital infrared (IR) imaging devices, have been cleared for marketing only for use with another screening or diagnostic test like mammography, and not for use as a standalone diagnostic tool, and that there is no valid scientific data to demonstrate that thermography devices are an effective screening tool for any medical condition, including the early detection of breast cancer or other diseases and health conditions. Thermography is not a substitute for regular mammograms, and should not be used in place of mammography for breast cancer screening or diagnosis.

The FDA also issued several recommendations for health care providers, including that they educate patients about the limitations of thermography, such as that the high false negative and false positive rates of thermography can provide misleading information that could result in a delayed diagnosis or unnecessary medical follow up. Providers should also discourage the use of thermography to diagnose or screen for breast cancer and talk to patients or caregivers about safe and effective ways to screen for breast cancer, including the benefits and risks of available testing options, clinical breast exams, and other breast imaging options such as ultrasound or MRI, or breast tissue biopsy.

“The FDA is aware that health spas, homeopathic clinics, mobile health units, and other health care facilities are using thermography inappropriately as a standalone tool for breast cancer screening or diagnosis,” stated the FDA. “These types of facilities provide false information that can mislead patients into believing that thermography can find breast cancer years before it would be detected through other methods or thermography improves detection of cancer in dense breasts.”

Thermography refers to digital infrared thermal imaging (DITI), a test that detects temperature changes on the surface of the skin using an IR thermal camera to record the areas of different temperature in the breasts. The camera displays these patterns as a heat map. As the presence of a tumor is associated with the excessive formation of blood vessels and inflammation in the breast tissue, the theory is that these changes should show up on the IR image as areas with a higher skin temperature.

Related Links:
Food and Drug Administration

Gold Member
Solid State Kv/Dose Multi-Sensor
AGMS-DM+
New
Silver Member
Mobile X-Ray Barrier
Lead Acrylic Mobile X-Ray Barriers
Digital Radiography Acquisition Software
VXvue with PureImpact
Crossover Angiography System
Trinias C16/C12/F12 Unity Smart Edition

Print article

Channels

Ultrasound

view channel
Image: Structure of the proposed transparent ultrasound transducer and its optical transmittance (Photo courtesy of POSTECH)

Ultrasensitive Broadband Transparent Ultrasound Transducer Enhances Medical Diagnosis

The ultrasound-photoacoustic dual-modal imaging system combines molecular imaging contrast with ultrasound imaging. It can display molecular and structural details inside the body in real time without... Read more

Nuclear Medicine

view channel
Image: PET/CT of a 60-year-old male patient with clinical suspicion of lung cancer (Photo courtesy of EJNMMI Physics)

Early 30-Minute Dynamic FDG-PET Acquisition Could Halve Lung Scan Times

F-18 FDG-PET scans are a way to look inside the body using a special dye, and these scans can be either static or dynamic. Static scans happen 60 minutes after the dye is administered into the body, showing... Read more

Imaging IT

view channel
Image: The new Medical Imaging Suite makes healthcare imaging data more accessible, interoperable and useful (Photo courtesy of Google Cloud)

New Google Cloud Medical Imaging Suite Makes Imaging Healthcare Data More Accessible

Medical imaging is a critical tool used to diagnose patients, and there are billions of medical images scanned globally each year. Imaging data accounts for about 90% of all healthcare data1 and, until... Read more

Industry News

view channel
Image: The acquisition will expand IBA’s medical imaging quality assurance offering (Photo courtesy of Radcal)

IBA Acquires Radcal to Expand Medical Imaging Quality Assurance Offering

Ion Beam Applications S.A. (IBA, Louvain-La-Neuve, Belgium), the global leader in particle accelerator technology and a world-leading provider of dosimetry and quality assurance (QA) solutions, has entered... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.